Compare NGNE & INVZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NGNE | INVZ |
|---|---|---|
| Founded | 2003 | 2016 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.8M | 273.5M |
| IPO Year | N/A | N/A |
| Metric | NGNE | INVZ |
|---|---|---|
| Price | $20.61 | $0.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $38.50 | $3.10 |
| AVG Volume (30 Days) | 188.3K | ★ 4.9M |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $48,442,000.00 |
| Revenue This Year | N/A | $146.75 |
| Revenue Next Year | N/A | $53.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 46.09 |
| 52 Week Low | $6.88 | $0.48 |
| 52 Week High | $37.27 | $3.14 |
| Indicator | NGNE | INVZ |
|---|---|---|
| Relative Strength Index (RSI) | 47.11 | 33.93 |
| Support Level | $19.28 | $0.84 |
| Resistance Level | $22.99 | $0.97 |
| Average True Range (ATR) | 1.44 | 0.08 |
| MACD | 0.32 | -0.01 |
| Stochastic Oscillator | 40.15 | 24.21 |
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.
Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.